"QUAD SHOT" Radiotherapy With Pembrolizumab in Patients With Recurrent Head & Neck Cancer
Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety of palliative "QUAD SHOT" radiotherapy
combined with pembrolizumab and evaluate the effects of the combination treatment patients
with recurrent cancer of head and neck.